Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.53 |
| ▸ | CASP1 | P29466 | 1/20 | 0.53 |
| ▸ | CASP7 | P55210 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 6/20 | 0.41 |
| ▸ | GAA | P10253 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29438231 | 1.00 | CYP3A4 (0.53) | CYP3A4ALOX15CASP1CASP7SMN1; SMN2 | |
| SCHEMBL17221914 | 0.85 | GAA (0.42) | CYP3A4ALOX15CASP1CASP7SMN1; SMN2 | |
| SCHEMBL30589669 | 0.84 | CYP3A4 (0.43) | CYP3A4ALOX15CASP1CASP7SMN1; SMN2 | |
| SCHEMBL572997 | 0.84 | CYP3A4 (0.43) | CYP3A4ALOX15CASP1CASP7SMN1; SMN2 | |
| SCHEMBL4845351 | 0.84 | CYP3A4 (0.43) | CYP3A4ALOX15CASP1CASP7SMN1; SMN2 | |
| SCHEMBL7192114 | 0.83 | TSHR (0.41) | CYP3A4ALOX15CASP1CASP7SMN1; SMN2 | |
| SCHEMBL30602819 | 0.80 | CYP3A4 (0.39) | CYP3A4ALOX15CASP1CASP7SMN1; SMN2 | |
| SCHEMBL11241782 | 0.79 | CYP3A4 (0.50) | CYP3A4ALOX15CASP1CASP7SMN1; SMN2 | |
| SCHEMBL11774848 | 0.79 | CYP3A4 (0.50) | CYP3A4ALOX15CASP1CASP7SMN1; SMN2 | |
| SCHEMBL30365237 | 0.79 | CYP3A4 (0.50) | CYP3A4ALOX15CASP1CASP7SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0931280-B1 | ELECTROPHOTOGRAPHIC CARRIER COMPOSITIONS HAVING IMPROVED LIFE | NASHUA CORP (US) | 2000-08-02 | — | — | EP | claimed |
| US-4196274-A | REACTING A POLYSISCYANATE OR POLYISOTHIOCYANATE WITH A MALEAMIC ACID | BAYER AKTIENGESELLSCHAFT (DE) | 1980-04-01 | — | — | US | claimed |
| US-20260071042-A1 | SYSTEMS AND METHODS FOR PRODUCING AEROGEL MATERIALS | AEROGEL TECHNOLOGIES, LLC (US) | 2026-03-12 | — | — | US | disclosed |
| US-20250340753-A1 | THIN CORROSION PROTECTIVE COATINGS INCORPORATING POLYAMIDOAMINE POLYMERS | HENKEL AG & CO KGAA (DE) | 2025-11-06 | — | — | US | disclosed |
| US-12365812-B2 | Thin corrosion protective coatings incorporating polyamidoamine polymers | HENKEL AG & CO. KGAA (DE) | 2025-07-22 | — | — | US | disclosed |
| US-20250136838-A1 | POLYCARBONATE-BASED POLYURETHANE TOPCOATS | PRC-DESOTO INTERNATIONAL, INC. (US) | 2025-05-01 | — | — | US | disclosed |
| WO-2025038342-A1 | DUAL CURE EPOXY COATINGS AND METHODS OF MAKING THE SAME | SWIMC LLC (US) | 2025-02-20 | — | — | WO | disclosed |
| CN-112703452-B | Magenta toner and method for producing the same | 日本瑞翁株式会社 | 2024-12-27 | — | — | CN | disclosed |
| US-20240425448-A1 | METHOD FOR PRODUCING ISOCYANATE COMPOUND, METHOD FOR PRODUCING CARBAMATE COMPOUND, METHOD FOR RECOVERING AMINE COMPOUND, AND ISOCYANATE COMPOSITION | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2024-12-26 | — | — | US | disclosed |
| EP-4473028-A1 | POLYCARBONATE-BASED POLYURETHANE TOPCOATS | PRC-Desoto International, Inc. (US) | 2024-12-11 | — | — | EP | disclosed |
| US-20240343877-A1 | SYSTEMS AND METHODS FOR PRODUCING AEROGEL MATERIALS | AEROGEL TECHNOLOGIES, LLC (US) | 2024-10-17 | — | — | US | disclosed |
| US-4296218-A | Heat-curable and solvent-soluble ester group-containing polymer compositions and process for their preparation | TEIJIN LIMITED (JP) | 1981-10-20 | — | — | US | disclosed |
| US-4281140-A | REACTING AN ISOCYANATE OR ISOTHIOCYANATE WITH AN UNSATURATED DIAMINE | BAYER AKTIENGESELLSCHAFT (DE) | 1981-07-28 | — | — | US | disclosed |
| US-4251649-A | COMPRISING A LOW MOLECULAR WEIGHT MODIFIER POLYESTER AND A POLYFUNCTIONAL HYDROXY OR AMINE | TEIJIN LIMITED (JP) | 1981-02-17 | — | — | US | disclosed |
| US-4228053-A | Concrete preparation with aqueous solution of product from polyether with polymethylene polyphenyl polyisocyanate | THE UPJOHN COMPANY (US) | 1980-10-14 | — | — | US | disclosed |
| US-4220563-A | Heat-curable and solvent-soluble ester group-containing polymer compositions and process for their preparation | TEIJIN LIMITED (JP) | 1980-09-02 | — | — | US | disclosed |
| US-4196274-A | REACTING A POLYSISCYANATE OR POLYISOTHIOCYANATE WITH A MALEAMIC ACID | BAYER AKTIENGESELLSCHAFT (DE) | 1980-04-01 | — | — | US | disclosed |
| US-4182812-A | FROM POLYISOCYANATES OR POLYISOTHIOCYANATES AND AN UNSATURATED DIAMIDE | BAYER AKTIENGESELLSCHAFT (DE) | 1980-01-08 | — | — | US | disclosed |
| US-4143014-A | STORAGE STABLE SOLUTION OF POLYOXY-PROPYLENE OR ETHYLENE GLYCOL AND POLYMETHYLENEPOLYPHENYLENE POLYISOCYANATE | THE UPJOHN COMPANY (US) | 1979-03-06 | — | — | US | disclosed |
| US-4137221-A | Heat-curable and solvent-soluble ester group-containing polymer compositions and process for their preparation | TEIJIN LIMITED (JP) | 1979-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071042-A1 | SYSTEMS AND METHODS FOR PRODUCING AEROGEL MATERIALS | TERT, TAF11, TAF1 | CYP3A4 1834/4885ALOX15 3035/4885CASP1 725/4885 |
| US-20240425448-A1 | METHOD FOR PRODUCING ISOCYANATE COMPOUND, METHOD FOR PRODUCING CARBAMATE COMPOUND, METHOD FOR RECOVERING AMINE COMPOUND, AND ISOCYANATE COMPOSITION | IDH3A, CA7, C9 | CYP3A4 182/4885ALOX15 1785/4885CASP1 112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.